Shanghai Rendu Biotechnology Co

Shanghai Rendu Biotechnology Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Shanghai Rendu Biotechnology Co (688193.SS) as of Oct 17, 2026 is 190.28. In the previous year, Cash Conversion Cycle (CCC) was 323.33 — a change of -41.15% (lower).

Cash Conversion Cycle

190.28

YoY

-41.15%

Last updated:

Cash Conversion Cycle (CCC) of Shanghai Rendu Biotechnology Co is 2025 190.28 . Cash Conversion Cycle (CCC) of Shanghai Rendu Biotechnology Co was 2024 323.33 . It decreases by -41.15% lower compared to the previous year.

The Shanghai Rendu Biotechnology Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
284.83 CNY
Jan 1, 2019
356.57 CNY
Jan 1, 2020
107.94 CNY
Jan 1, 2021
116.05 CNY
Jan 1, 2022
184.90 CNY
Jan 1, 2023
460.70 CNY
Jan 1, 2024
323.33 CNY
Jan 1, 2025
190.28 CNY
The Shanghai Rendu Biotechnology Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
190.28-41.15%
323.33-29.82%
460.70+149.16%
184.90+59.33%
116.05+7.51%
107.94-69.73%
356.57+25.18%
284.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co Ltd develops molecular diagnostic tests using RNA isothermal amplification technology, offering reagents for respiratory, reproductive, enterovirus, and blood-borne disease diagnostics. Headquartered in Shanghai, China, the company employs 528 full-time staff and operates primarily within the domestic market. Listed on March 30, 2022, it designs and manufactures medical instruments alongside its diagnostic products. Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Cash Conversion Cycle (CCC) of Shanghai Rendu Biotechnology Co is 190.28 in 2025.

Cash Conversion Cycle (CCC) of Shanghai Rendu Biotechnology Co changed from 323.33 to 190.28, representing a -41.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Shanghai Rendu Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Shanghai Rendu Biotechnology Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Shanghai Rendu Biotechnology Co